TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population.
暂无分享,去创建一个
[1] F. Garrido,et al. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an eastern Andalusian population. , 2005, Human immunology.
[2] J. Bodmer,et al. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2 , 2004, Immunogenetics.
[3] J. Bodmer,et al. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2 , 1993, Immunogenetics.
[4] L. Chouchane,et al. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. , 2003, Cancer letters.
[5] S. Cha,et al. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. , 2003, Gynecologic oncology.
[6] A. Khabir,et al. Similar BCL-X but different BCL-2 levels in the two age groups of north African nasopharyngeal carcinomas. , 2003, Cancer detection and prevention.
[7] K. Ayed,et al. Association between HLA-A/-B Antigens and -DRB1 Alleles and Nasopharyngeal Carcinoma in Tunisia , 2001, Oncology.
[8] A. Benider,et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma , 2001, International journal of cancer.
[9] J. Daoud,et al. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] S. Leung,et al. CTL Control of EBV in Nasopharyngeal Carcinoma (NPC): EBV-Specific CTL Responses in the Blood and Tumors of NPC Patients and the Antigen-Processing Function of the Tumor Cells1 , 2000, The Journal of Immunology.
[11] D. Singal,et al. Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism. , 1998, Immunology letters.
[12] L. Sobin,et al. TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.
[13] M. Nijenhuis,et al. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. , 1996, Journal of immunology.
[14] Parkin Dm,et al. Cancer Incidence in Five Continents. Comparability and quality of data. , 1992 .
[15] G. de‐Thé,et al. Diet, living conditions and nasopharyngeal carcinoma in tunisia—a case‐control study , 1990, International journal of cancer.
[16] U. Prasad,et al. HLA and nasopharyngeal carcinoma in Malays. , 1985, British Journal of Cancer.
[17] N. Day,et al. HLA and nasopharyngeal carcinoma in chinese —A further study , 1983, International journal of cancer.
[18] M. Cammoun,et al. Tumors of the nasopharynx in Tunisia. An anatomic and clinical study based on 143 cases , 1974, Cancer.
[19] L. Old,et al. PRECIPITATING ANTIBODY IN HUMAN SERUM TO AN ANTIGEN PRESENT IN CULTURED BURKITT'S LYMPHOMA CELLS* , 1966, Proceedings of the National Academy of Sciences of the United States of America.